Top Markets
Coin of the day
Galderma Group AG Galderma Group AG

Galderma Group AG

GALD
Rank in Stocks #472
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Share Price
$228.90
Market Cap
$53.38B
Change (1 day)
0.06%
Change (1 year)
39.80%
Country
CH
Trade Galderma Group AG (GALD)

Category

P/B ratio for Galderma Group AG (GALD)
P/B ratio as of 2026 TTM: 0
According to Galderma Group AG latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Galderma Group AG from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors